EMS-Chemie Holding AG | Chair election at EMS-Chemie Holding AG
How other organisations have declared their voting intentions
Organisation name | Declared voting intentions | Rationale |
---|---|---|
AP7 | Against | AP7 intends to vote against Mr Bernhard Merki (Item 6.1.1), the chair of the board of Swiss chemical manufacturer EMS-Chemie Holding AG. The vote marks AP7’s dissatisfaction with the company’s climate-related disclosure, which provides insufficient transparency on the company’s climate transition strategy and governance. A vote against the chair is in line with AP7’s intent to hold the Board of Directors accountable for delivering credible climate transition plans as published earlier this year https://www.ap7.se/aktuellt/board-responsibility-for-climate-transition-in-focus-during-the-agm-season/ In an evaluation by Transition Pathway Initiative (TPI) of the company’s public disclosure, EMS-Chemie receives a Management Quality score of 1. Only 2 of 57 chemical companies assessed by TPI receive this bottom-ranked score. The very recently released 2022 Sustainability Report and the 2023 CDP Climate Change submission demonstrate some improvements in transparency, which is welcomed. |
DISCLAIMER: By including a shareholder resolution or management proposal in this database, neither the PRI nor the sponsor of the resolution or proposal is seeking authority to act as proxy for any shareholder; shareholders should vote their proxies in accordance with their own policies and requirements.
Any voting recommendations set forth in the descriptions of the resolutions and management proposals included in this database are made by the sponsors of those resolutions and proposals, and do not represent the views of the PRI.
Information on the shareholder resolutions, management proposals and votes in this database have been obtained from sources that are believed to be reliable, but the PRI does not represent that it is accurate, complete, or up-to-date, including information relating to resolutions and management proposals, other signatories’ vote pre-declarations (including voting rationales), or the current status of a resolution or proposal. You should consult companies’ proxy statements for complete information on all matters to be voted on at a meeting.